Skip to main content

Advertisement

SpringerLink
Log in

The use of baclofen in cluster headache

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Cluster headache is a rare, clinically well-characterized disabling disorder that occurs in both episodic and chronic forms. The very painful short-lived unilateral headache attacks are associated with autonomic dysfunction. A large number of drugs such as ergotamines, steroids, methysergide, lithium carbonate, verapamil, valproate, capsaicin, leuprolide, clonidine, methylergovine maleate, methylphenidate, and melatonin are considered beneficial for prophylaxis. Nevertheless, this extremely painful condition is occasionally refractory to conventional treatment.

The antispastic agent baclofen has been shown to possess an antinociceptive activity. Its efficacy in neuralgias, central pain following spinal lesions, painful strokes, migraine, and medication misuse chronic daily headache suggests that it may be useful for prevention of cluster headache attacks. Therefore, we treated 16 symptomatic patients with cluster headache with daily baclofen, 15 to 30 mg, in three divided doses for the cluster period and 2 weeks after. Within a week, 12 patients reported the cessation of attacks. One was substantially better and became attack free by the end of the following week. In the remaining three patients, the attacks worsened and corticosteroids were prescribed. One of these was also given verapamil. Three of the 16 patients had an additional cluster period, which cleared with a second course of baclofen. In this pilot study, baclofen seemed to be effective, safe, and well tolerated for cluster headache, and seemed to retain its efficacy on repeated clusters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. D’Alessandro R, Gamberini G, Benassi G, et al.: Cluster headache in the Republic of San Marino. Cephalalgia 1986, 6:159–162.

    Article  PubMed  CAS  Google Scholar 

  2. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(suppl 7):1–96.

    Google Scholar 

  3. Nappi G, Micieli G, Cavallini A, et al.: Accompanying symptoms of cluster attacks: their relevance to the diagnostic criteria. Cephalalgia 1992, 12:165–168.

    Article  PubMed  CAS  Google Scholar 

  4. Ekbom KA: Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 1981, 21:132–139.

    Article  PubMed  CAS  Google Scholar 

  5. Ekbom KA: Treatment of cluster headache: clinical trials, design and results. Cephalalgia 1995, 15(suppl 15):33–36.

    PubMed  Google Scholar 

  6. Ekbom KA: Ergotamine tartarate orally in Horton’s "histaminic cephalgia" (also called Harris’s "cilliary neuralgia"). Acta Psychiatry Scand 1947, 46(suppl):103–113.

    Google Scholar 

  7. Couch JR, Ziegler DK: Prednisone therapy for cluster headache. Headache 1978, 18:219–221.

    Article  PubMed  Google Scholar 

  8. De CarolisP, de CapoaD, Agati R, et al.: Episodic cluster headache: short and long term results of prophylactic treatment. Headache 1988, 28:475–476.

    Article  PubMed  Google Scholar 

  9. Sicuteri F: Prophylactic and therapeutic properties of 6-methyl-lysergic acid butanolamide in migraine. Int Arch Allergy Immunol 1959, 15:300–307.

    Article  CAS  Google Scholar 

  10. Kudrow L: Lithium prophylaxis for chronic cluster headache. Headache 1977, 17:15–18.

    Article  PubMed  CAS  Google Scholar 

  11. Manzoni GC, Bono G, Lanfranchi M, et al.: Lithium carbonate in cluster headache: assessment of its short- and long-term therapeutic efficacy. Cephalalgia 1983, 3:109–114.

    Article  PubMed  CAS  Google Scholar 

  12. Steiner TJ, Hering R, Couturier EGM, et al.: Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia 1997, 17:673–675.

    Article  PubMed  CAS  Google Scholar 

  13. Bussone G, Leone M, Peccarisi C, et al.: Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990, 30:411–417.

    Article  PubMed  CAS  Google Scholar 

  14. Meyer JC, Hardenberg J: Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache 1983, 23:266–277.

    Article  PubMed  CAS  Google Scholar 

  15. Gabai IJ, Spierings ELM: Prophylactic treatment of cluster headache with verapamil. Headache 1989, 29:167–168.

    Article  PubMed  CAS  Google Scholar 

  16. Hering R, Kuritzky A: Sodium valproate in the treatment of cluster headache: an open trial. Cephalalgia 1989, 9:196–198. This article was the first one to show the importance of GABA agonists in the treatment of cluster headache.

    Article  Google Scholar 

  17. Wheeler SD: Significance of migrainous features in cluster headache: divalproex responsiveness. Headache 1998, 38:547–551.

    Article  PubMed  CAS  Google Scholar 

  18. Sicuteri F, Fusco BM, Marabini M, et al.: Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin J Pain 1989, 5:49–53.

    Article  PubMed  CAS  Google Scholar 

  19. Fusco BM, Fiore G, Gallo F, et al.: "Capsaicin-sensitive" sensory neurons in cluster headache: pathophysiological aspects and therapeutic indication. Headache 1994, 34:132–137.

    Article  PubMed  CAS  Google Scholar 

  20. Nicolodi M, Sicuteri F, Poggioni M: Hypothalamic modulation of nociception and reproduction in cluster headache. 1. Therapeutic trials of leuprolide. Cephalalgia 1993, 13:253–257.

    Article  PubMed  CAS  Google Scholar 

  21. D’Andrea G, Perini F, Granella F, et al.: Efficacy of transdermal clonidine in short-term treatment of cluster headache: a pilot study. Cephalalgia 1995, 15:430–433.

    Article  PubMed  CAS  Google Scholar 

  22. Leone M, Attanasio A, Grazzi L, et al.: Transdermal clonidine in the prophylaxis of episodic cluster headache. Cephalalgia 1997, 17:551.

    Article  PubMed  CAS  Google Scholar 

  23. Leone M, Attanasio A, Grazzi L, et al.: Transdermal clonidine in the prophylaxis of episodic cluster headache: an open study. Headache 1997, 37:559–560.

    Article  PubMed  CAS  Google Scholar 

  24. Mueller L, Gallagher RM, Ciervo CA: Methylergonovine maleate as a cluster headache prophylactic: a study and review. Headache. 1997, 37:437–442.

    Article  PubMed  CAS  Google Scholar 

  25. Leone M, D’Amico D, Moschiano F, et al.: Melatonin versus placebo in the prophylaxis of cluster headache: a doubleblind pilot study with parallel groups. Cephalalgia 1996, 16:494–496.

    Article  PubMed  CAS  Google Scholar 

  26. Mellick GA, Mellick LB: Cluster headache management with methylphenidate (Ritalin). Headache 1998, 38:710–712.

    Article  PubMed  CAS  Google Scholar 

  27. Onofrio BM, Campbell JK: Surgical treatment of chronic cluster headache. Mayo Clin Proc 1986, 61:537–544.

    PubMed  CAS  Google Scholar 

  28. Lovely TJ, Kotsiakis X, Jannetta PJ: The surgical management of chronic cluster headache. Headache 1998, 38:590–594.

    Article  PubMed  CAS  Google Scholar 

  29. Bowery NG, Hill DR, Hudson AL, et al.: Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 1980, 283:92–94.

    Article  PubMed  CAS  Google Scholar 

  30. Hill DR, Bowery NG: 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nature 1981, 290:149–152.

    Article  PubMed  CAS  Google Scholar 

  31. Levy RA, Proudfit HK: Analgesia produced by microinjection of baclofen and morphine at brain stem sites. Eur J Pharmacol 1979, 57:43–55.

    Article  PubMed  CAS  Google Scholar 

  32. Liebman JM, Pastor G: Antinociceptive effects of baclofen and muscimol upon intraventricular administration. Eur J Pharmacol 1980, 61:225–230.

    Article  PubMed  CAS  Google Scholar 

  33. Davidoff RA: Antispasticity drugs: mechanisms of action. Ann Neurol 1985, 17:107–116.

    Article  PubMed  CAS  Google Scholar 

  34. Fromm GH, Chatta AS, Terrence CF, Glass JD: Role of inhibitory mechanisms in trigeminal neuralgia. Neurology 1981, 31:683–687.

    PubMed  CAS  Google Scholar 

  35. Bowsher D: Neurogenic pain syndromes and their management. Br Med Bull 1991, 47:655–666.

    Google Scholar 

  36. Ringel RA, Roy EPIII: Glossopharyngeal neuralgia: successful treatment with baclofen. Ann Neurol 1987, 21:514–515.

    Article  PubMed  CAS  Google Scholar 

  37. Herman RM, D’Luzansky SC, Ippolito R: Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 1992, 8:338–345.

    Article  PubMed  CAS  Google Scholar 

  38. Taira T, Tanikawa T, Kawamura H, et al.: Spinal intrathecal baclofen suppresses central pain after a stroke. J Neurol Neurosurg Psychiatry 1994, 57:381–382.

    Article  PubMed  CAS  Google Scholar 

  39. Hering R: Baclofen in the prevention of migraine. Cephalalgia 1997, 17:436.

    Google Scholar 

  40. Hering R: Abrupt withdrawal of medication using baclofen in migraineurs with chronic daily headache [abstract]. Cephalalgia 1997, 17:460.

    Google Scholar 

  41. Ekbom KA, Greitz T: Carotid angiography in cluster headache [abstract]. Acta Radiol Diagn 1970, 10:177–186.

    CAS  Google Scholar 

  42. Hannerz J: Orbital phlebography and signs of inflammation in episodic and chronic cluster headache. Headache 1991, 31:540–542.

    Article  PubMed  CAS  Google Scholar 

  43. Goadsby PJ, Edvinsson L: Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994, 117:427–434.

    Article  PubMed  Google Scholar 

  44. Remahl IN, Waldenlind E, Bratt J, Ekbom KA: Cluster headache is not associated with signs of a systemic inflammation. Headache 2000, 40:276–281. The mechanisms of pain in cluster headache are yet unknown. In this investigation, no evidence was found for systemic inflammation in cluster headache.

    Article  PubMed  CAS  Google Scholar 

  45. May A, Bahra A, Buchel C, et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275–278. Areas of gray matter in the hypothalamus that regulate internal pacemaker rhythms are at the focus of research at present. Activation in the ipsilateral hypothalamus, as well as increase in regional cerebral blood flow, were demonstrated in these patients, suggesting an involvement of the hypothalamic gray as a primum movens in the acute cluster attack.

    Article  PubMed  CAS  Google Scholar 

  46. Sawynok J: GABAergic mechanisms in antinociception. Prog Neuropsychopharmacol Biol Psych 1984,43:636–638.

    Google Scholar 

  47. Huston E, Scott RH, Dolphin AC: A comparison of the effect of calcium channel ligands and GABAB agonists and antagonists on transmitter release and somatic calcium channel currents in cultured neurons. Neuroscience 1990, 38:721–729.

    Article  PubMed  CAS  Google Scholar 

  48. Losada ME, Acosta GB: Effects of baclofen on amino acid release. Eur J Pharmacol 1992, 224:21–25.

    Article  PubMed  CAS  Google Scholar 

  49. Thompson SM, Gahwiler BH: Comparison of the actions of baclofen at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol (Lond) 1992, 451:329–345.

    CAS  Google Scholar 

  50. Saito K, Konishi S, Otsuka M: Antagonism between Lioresal and substance P in rat spinal cord. Brain Res 1975, 97:177–180.

    Article  PubMed  CAS  Google Scholar 

  51. Sawynok J, Moochhala SM, Pillay DJ: Substance P, injected intrathecally, antagonizes the spinal antinociceptive effect of morphine, baclofen and noradrenaline. Neuropharmacology 1984, 23:741–747.

    Article  PubMed  CAS  Google Scholar 

  52. Hwang AS, Wilcox GL: Baclofen, gamma aminobutyric acidB receptors and substance P in mouse spinal cord. J Pharmacol Exp Ther 1989, 248:1026–1033.

    PubMed  CAS  Google Scholar 

  53. Cutrer FM, Limmroth V, Ayata G, Moskowitz MA: Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 1995, 116:3199–3204.

    PubMed  CAS  Google Scholar 

  54. Hammond DL, Nelson V, Thomas DA: Intrathecal methysergide antagonizes the antinociception, but not the hyperalgesia produced by microinjection of baclofen in the ventromedial medulla of the rat. Neurosci Lett 1998, 244:93–96.

    Article  PubMed  CAS  Google Scholar 

  55. D’Andrea G, Granella F, Alecci M, Manzoni GC: Serotonin metabolism in cluster headache. Cephalalgia 1998, 18:94–96. Serotonin metabolism plays a pivotal role in pain and was suggested to play an important role in cluster headache as well. In this study, plasma serotonin metabolism was found to be elevated, suggesting involvement of a central serotonergic system in the pathogenesis of cluster headache.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Meir General Hospital, Sapir Medical Center, 59 Jabotinski Street, 44288, Kfar Saba, Israel

    Rachel Hering-Hanit MD

Authors
  1. Rachel Hering-Hanit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Natan Gadoth MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hering-Hanit, R., Gadoth, N. The use of baclofen in cluster headache. Current Science Inc 5, 79–82 (2001). https://doi.org/10.1007/s11916-001-0014-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-001-0014-1

Keywords

Search

Navigation